The product 2 was prepared via a direct condensation under solid-liquid phase transfer catalysis (S.L.P.T.C.) [1] conditions. To a solution of 0.02 mmole of tetraglyme in 4 ml of anhydrous THF, 0.11 mmole of potassium tert-butoxide is added. Then 0.1 mmole of the acyclonucleoside 1 [2] is added, the reaction mixture is stirred at room temperature for 15 min. The reaction mixture is cooled to 0°C and 0.11 mmole of alkylating agent in 2 ml of dry THF is added dropwise with stirring. When the addition is finished, the reaction mixture is stirred at 0°C for 30 min. The reaction mixture is then filtered and the filtrate is evaporated in vacuo to dryness. The residue is then chromatographed on a silica gel column and the expected acyclonucleoside 2 was isolated. Yield: 80 %. Rf: 0.51 (CHCl 3 / MeOH, 9/1, V/V). M.p.: 78-80°C (CHCl 3 ). 1 H NMR (DMSO-d 6 ): 1.20 (t, 3H, CH 3 CH 2 ); 2.00 (s, 3H, COOCH 3 ); 3.70 (m, 2H, OCH 2 CH 2 O); 4.10 (m, 2H, OCH 2 CH 2 O); 4.20 (q, 2H, CH 3 CH 2 ); 4.75 (s, 2H, NCH 2 ); 5.25 (s, 2H, OCH 2 N). UV (l max (nm), H 2 O): 283. MS (m/z): 393 [M ( 79 Br)] + , 395 [M ( 81 Br)] + Anal. calc. for C 12 H 16 BrN
